A memorial service honoring the life of Julius B. Richmond will be held Oct. 27 at 10 a.m. at the Harvard Club of Boston, 347 Commonwealth Ave. A reception will follow. A former U.S. surgeon general, Richmond held appointments at the Harvard School of Public Health, Harvard Medical School, and the Harvard Kennedy School. He died on July 27.
AddThis Sharing ButtonsShare to FacebookFacebookFacebookShare to TwitterTwitterTwitterShare to EmailEmailEmailShare to RedditRedditRedditShare to MoreAddThisMoreThe most popular course at Harvard this semester teaches the skill of positive thinking. 855 students signed up for a positive psychology course to learn how to create “a fulfilling and flourishing life.” Harvard is one of about a hundred campuses around the country offering courses that focus on what helps people to feel good. Positive Psychology is the empirical study of such things as positive emotions, strengths-based character, and healthy institutions. Growing piles of scientific research are promoted on the covers of magazines like Time, and leading to masters degree programs, like the one centered on the work of Dr. Martin Seligman, the founder of Positive Psychology. The University of PA offers to professionals, many of whom are working full-time, the chance to earn a pioneering graduate degree from the Ivy League university, with the Master of Applied Positive Psychology (MAPP). International conferences on the topic are now numerous. The Fifth International Positive Psychology Summit will be held in Washington, DC on October 5- 7, 2006 and sponsored by The Gallup Organization with Toyota and Toyota University.Read more about Harvard students and their class in the Boston Globe, (If you don’t want to register for reading page 2, read it here) NPR did a story also and includes its audio/ radio file.AddThis Sharing ButtonsShare to FacebookFacebookFacebookShare to TwitterTwitterTwitterShare to EmailEmailEmailShare to RedditRedditRedditShare to MoreAddThisMore
AddThis Sharing ButtonsShare to FacebookFacebookFacebookShare to TwitterTwitterTwitterShare to EmailEmailEmailShare to RedditRedditRedditShare to MoreAddThisMoreThe billionaire philanthropist David M. Rubenstein will donate $7.5 million to help fix the shuttered, earthquake-damaged Washington Monument, government officials announced Thursday.The gift once again confirmed Rubenstein’s status as a generous repeat benefactor for Washington’s endangered national icons.It comes a month after he donated $4.5 million to the National Zoo’s cash-strapped giant panda program and seven months after a $13.5 million gift to the National Archives.(READ the story in Washington Post)Photo by DAVID ILIFF. License: CC-BY-SA 3.0AddThis Sharing ButtonsShare to FacebookFacebookFacebookShare to TwitterTwitterTwitterShare to EmailEmailEmailShare to RedditRedditRedditShare to MoreAddThisMore
For Shimano, WTC will be selling rings for both the new XT M8000 96mm BCD crank as well as 110 asymmetric 4 bolt road cranks. Other than their new fitting, the rings carry all of the same features and benefits of WTC elliptical rings with their patent pending Drop-Stop tooth profile and 7075-T6 aluminum construction. Using standard shape, the rings have a 10° ovality and 112° timing after Top Dead Center. The XT M8000 elliptical will sell for $64.95 in 30, 32, and 34t while the 110 4 bolt BCD ring will be a little more at $78.95 in 38, 40, and 42t.Photos c. WTCBig news for fat bike riders is the addition of a reverse dish elliptical ring for RaceFace Cinch cranks. For a while now, fat bikers have been reversing the rings on Cinch cranks which offsets the dish towards the outside of the bike. This allows for proper chain line when running a crankset designed for a 170mm dropout bike on 190mm frame. Anyone who has pedaled the monstrous q-factor of a true 190mm (dropout) crank knows how big of deal this actually is.Now, WTC is offering an elliptical chainring that is meant for this exact use. When used with a crank meant for a 170mm fat bike, the ring provides a 75mm chainline that is ideal for 190/197mm dropout frames. Selling for $69.95, the rings will be sold in 28, 30, and 32t options with 30t shipping now.wolftoothcomponents.com If you’re a fan of the elliptical chainring, Wolf Tooth Components should have your attention. Following in the pedal strokes of a number of previous Drop-Stop elliptical rings, WTC is introducing three more designs to continue to add compatibility.MFor those that aren’t current on all of the chainring standards, there have been a number of new BCDs and bolt spacings introduced in recent years which makes the addition of new rings a necessity…
The Lifespan of a Fact Related Shows View Comments Production art for “The Lifespan of a Fact”(Provided by Polk & Co.) Show Closed This production ended its run on Jan. 13, 2019 The upcoming world premiere production of The Lifespan of a Fact will break ground this fall, featuring Broadway’s first all-female lineup of designers, according to the production. The play is set to appear at Studio 54 beginning on September 20 with an opening scheduled for October 18.The Lifespan of a Fact will feature scenic design by Tony winner Mimi Lien (Natasha, Pierre & the Great Comet of 1812), costume design by Tony winner Linda Cho (A Gentleman’s Guide to Love and Murder), lighting design by Jen Schriever (Eclipsed), sound design by Palmer Hefferan (Sugar in Our Wounds) and projection design by Lucy Mackinnon (Six Degrees of Separation).As previously announced, the three-hander will star Daniel Radcliffe, two-time Tony winner Cherry Jones and two-time Tony nominee Bobby Cannavale. The Lifespan of a Fact is written by Jeremy Kareken, David Murrell and Gordon Farrell, and based on the book written by John D’Agata and Jim Fingal. Tony nominee Leigh Silverman will direct.Framed around the true story of D’Agata’s essay What Happens There, the play follows Fingal (played by Radcliffe), who has a small job: to fact-check articles for one of the best magazines in the country. His boss (Jones) has given him a big assignment: to apply his skill to a groundbreaking piece by legendary author D’Agata (Cannavale). But now Fingal has a huge problem: D’Agata made up a lot of his article. What starts professional quickly becomes profane.The Lifespan of a Fact is scheduled to play a 16-week limited engagement through January 13, 2019.
Star Files Chita Rivera View Comments Due to the global COVID-19 pandemic, the upcoming Chita Rivera Awards ceremony, originally scheduled for May 17 at NYU’s Skirball Center for the Performing Arts, has been pushed back to later in the year. Further details will be announced in the coming weeks.Carrying the namesake of one of the great dance icons of the American musical theater, the Chita Rivera Awards honors superb achievement in dance and choreographic excellence. Through education and scholarships, the awards aim to nurture future generations and preserve notable dance history.The Chita Rivera Awards is the latest theater honor to postpone its ceremony because of COVID-19. Also recently postponed is the Outer Critics Circle Awards, Theatre World Awards, Helen Hayes Awards and Broadway’s annual Tony Awards. London’s Olivier Awards ceremony was replaced by a TV special, while off-Broadway’s Lucille Lortel Awards will be held this spring as a virtual online broadcast.
by Andrew Stein March 28, 2013 vtdigger.org A stripped-down version of S30 sailed smoothly through the Senate on Thursday, and now it’ s headed to a skeptical House committee.The controversial Senate bill, which initially proposed a three-year moratorium on utility scale wind developments, was gutted on Tuesday. The previous version of the bill would have given municipalities greater leverage over the permitting process by applying criteria from Act 250, the state’ s governing land-use law.The draft that the Senate passed allocates $75,000 for a series of economic, environmental and health assessments associated with wind turbine projects that the Public Service Department would carry out. The bill would refine the structure of the Joint Energy Committee, and it would charge the committee with reviewing the studies and the findings of the energy siting commission,which was created by Gov. Peter Shumlin in response to issues raised with the current siting process.The bill also makes clear that commercial construction, including that of electric power plants, is prohibited ‘ within any state park or forest.’Rep. Tony Klein, who chairs the House Natural Resources and Energy Committee, was staunchly against the initial version of S.30. As the bill comes to his committee, he says his team will focus solely on the studies.‘ We will be focusing in on what it is that’ s going to be studied and what the tone is going to be,’ he said. ‘ My first impression of the read, and I intend to change that, is that it seems to be implying that renewables are bad, and I would rather change it to start with the premise that renewables are good.’That means Klein’ s committee will take limited testimony.‘ It’ s not going to be an open door policy because it’ s a study and there are certain things that are being asked to be studied,’ he said. ‘ I don’ t need to hear from neighbors.’While no amendments were officially proposed to the bill, two were entertained in the Senate Natural Resources and Energy Committee prior to the vote.Sen. Tim Ashe crafted one of the amendments, which would have included electric and natural gas transmission lines in the proposed studies. Ashe’ s amendment also tweaked some of the bill’ s language, but did not propose any policy changes. He said his amendment stemmed from concerns he heard from Chittenden, Addison and Rutland county residents about the siting of transmission lines.Sen. John Rodgers, D-Essex Orleans, proposed the other amendment. His amendment would have required energy generation applicants to submit project plans to municipal and regional planning commissions six months prior to a permit request with the Public Service Board ‘ rather than 45 days, as is current practice.‘ I think there were a lot of important things that got stripped out of S.30,’ he said. ‘ If we’ re not going to do anything to help those small towns have a voice in front of the Public Service Board, then at least give them a little bit more of a warning.’While Rodgers was a strong proponent of the original bill, Ashe was not.Sen. Bob Hartwell, D-Bennington, is chair of the Senate Natural Resources and Energy Committee, which approved the version of the bill with the Act 250 language. He said his committee asked the two senators to table their amendments so that S.30 could move to the House with strong support from the body.Hartwell said that while the amendments were tabled, they might find their way into other bills later this session. He also said that he does not expect language from Act 250 to come back into play this session and a moratorium on wind projects is off the table.‘ There is not going to be any moratorium language,’ he said. ‘ I’ m not sure of everything, but I think I’ m sure of that.’Gabrielle Stebbins, director of the trade organization Renewable Energy Vermont, lobbied hard against the moratorium and the Act 250 criteria. She said she would not breathe a sigh of relief until the end of the session.‘ We will certainly be keeping our eye out because that is still something certain senators are very much wanting,’ she said about the moratorium and Act 250 language. ‘ If you look at last year’ s history on the Senate floor, we did see amendments like that.’As far as the current version of S.30 goes, she said she doesn’ t have any major qualms.‘ I think it’ s meaningful the senators want to continue to have this conversation and this debate because, realistically, we need to move forward together,’ she said. ‘ And if that’ s continuing the conversation, then let’ s do it.’
Master Trainer Dr Matt Torrington of the UCLA Integrated Substance Abuse Programs works closely with qualified healthcare providers to teach them best practices for insertion and removal of the Probuphine implant, a new treatment option for opioid use disorder. Braeburn photo.Vermont Business Magazine Braeburn Pharmaceuticals(link is external) announced today that healthcare provider training and certification for Probuphine will take place on July 29 and 30 in Burlington. Approved by the Food and Drug Administration (FDA)(link is external) on May 26, 2016, Probuphine is the first implant for the maintenance treatment of opioid dependence in patients who have sustained clinical stability on low-to-moderate doses of buprenorphine, specifically 8 mg or less per day. Healthcare providers in the Burlington area can register for Probuphine training here(link is external) or by calling 1-866-397-8939.Opioid use disorder is a chronic brain disease and one of the fastest growing public health epidemics in America. Last year in Vermont, 83 people died from an opioid overdose. Research has shown that opioid use disorder is best treated with a combination of medication and psychosocial support. The majority of individuals with opioid use disorder cannot sustain recovery without long-term outpatient medical treatment.”Braeburn is committed to making Probuphine available to patients in the Burlington area and across the country as soon as possible, which is why we’re conducting training sessions so quickly after receiving FDA approval for Probuphine,” said President and CEO Behshad Sheldon, Braeburn Pharmaceuticals. “We look forward to educating qualified healthcare providers in Burlington on July 29 and 30 on best practices for insertion and removal of Probuphine, the only treatment for opioid dependence that delivers medicine for up to six months. To date, 2,236 physicians from all 50 states and Puerto Rico have been certified to provide Probuphine to their patients.”Probuphine will not be distributed by pharmacies; patients can only receive the treatment from certified healthcare providers who have been specially trained to insert the implants just under the skin of the inside of the upper arm through an in-office procedure.This weekend’s training sessions for Probuphine in Burlington are part of a series of 262 that Braeburn is conducting across 55 cities this summer.About ProbuphineProbuphine is the only FDA approved long-acting buprenorphine treatment for opioid dependence. Probuphine delivers buprenorphine continuously for six months using Titan Pharmaceuticals’ (NASDAQ: TTNP) ProNeura™ technology. Probuphine is placed under the skin of the upper arm during an outpatient office procedure and is removed in a similar manner.For More Information on ProbuphineProbuphine is now available in all 50 U.S. States. Patients interested in Probuphine should visit the Probuphine Healthcare Provider Locator to find a trained and certified provider near them:www.probuphinerems.com/probuphine-locator(link is external).Probuphine is not distributed by pharmacies. Qualified healthcare providers can register for Probuphine training at www.probuphineREMS.com(link is external) or by calling 1-866-397-8939.WARNING: IMPLANT MIGRATION, PROTRUSION, EXPULSION and NERVE DAMAGE ASSOCIATED WITH INSERTION and REMOVALRisk Associated with Insertion and RemovalInsertion and removal of PROBUPHINE are associated with the risk of implant migration, protrusion, expulsion resulting from the procedure. Rare but serious complications including nerve damage and migration resulting in embolism and death may result from improper insertion of drug implants inserted in the upper arm. Additional complications may include local migration, protrusion and expulsion. Incomplete insertions or infections may lead to protrusion or expulsion.Because of the risks associated with insertion and removal, PROBUPHINE is available only through a restricted program called the PROBUPHINE REMS Program. All Healthcare Providers must successfully complete a live training program on the insertion and removal procedures and become certified, prior to performing insertions or prescribing PROBUPHINE implants. Patients must be monitored to ensure that PROBUPHINE is removed by a healthcare provider certified to perform insertions.Please see additional Important Safety Information in the Package Insert that can be found at probuphine.com or by following this link http://probuphinerems.com/wp-content/uploads/2016/02/final-approved-pi.pdf(link is external).About Opioid Use Disorder and Buprenorphine Opioid use disorder is a chronic brain disease and one of the fastest growing public health epidemics in America. In the U.S., 2.5 million people struggle with opioid addiction and, according to the Centers for Disease Control, 78 people die each day from the disease. There is a growing body of evidence that opioid addiction is not a choice or a moral failing, but the result of genetic predisposition combined with environmental factors. Nonetheless, individuals struggling with this disease continue to be stigmatized. Research has also shown that opioid use disorder is best treated with a combination of medication and psychosocial support. The majority of individuals with opioid addiction cannot sustain recovery without long-term outpatient medical treatment.Buprenorphine is a partial opioid agonist, which may help individuals to stop opioid use without experiencing withdrawal symptoms. Before FDA approval of Probuphine, buprenorphine was only available in oral form which must be taken daily.About Braeburn PharmaceuticalsBraeburn Pharmaceuticals, an Apple Tree Partners company, is a pharmaceutical company focused on long-acting therapeutic treatment options that are essential to improving patient outcomes and facilitating recovery in neurological and psychiatric disorders, which are often complicated by stigma and present significant public health challenges. Braeburn’s commercial product, Probuphine® (buprenorphine) implant was approved by the FDA in May 2016. Braeburn’s investigational product pipeline consists of long-acting implantable and injectable therapies for serious neurological and psychiatric disorders, including opioid addiction, pain, and schizophrenia. Braeburn’s pipeline products are at various stages of clinical development and include CAM2038, weekly and monthly subcutaneous injection depot formulations of buprenorphine, being investigated in opioid addiction and pain; a risperidone six-month implant being investigated in schizophrenia; and a novel molecule, ATI-9242, is being investigated for treatment of schizophrenia. More information on Braeburn, can be found atwww.braeburnpharmaceuticals.com(link is external).SOURCE BURLINGTON, Vt., July 26, 2016 /PRNewswire/ — Braeburn Pharmaceuticals, Inc.
Vermont Business Magazine Vermont’s unemployment rate fell one-tenth last month, but the better news was that both the labor force and the number of employed both increased, while the number of unemployed fell. The Vermont Department of Labor announced today that the seasonally-adjusted statewide unemployment rate for December was 3.1 percent. This reflects a decrease of one-tenth of one percentage point from the revised November rate (3.2 percent). December was also the first month since last May where both the adjusted and unadjusted jobs numbers increased. The national rate in December was 4.7 percent, up one-tenth.As of the prior month’s initial data, the Burlington-South Burlington Metropolitan NECTA was tied for eighth lowest unemployment rate in the country for all metropolitan areas at 2.3 percent (not-seasonally-adjusted). Overall, Vermont’s unemployment rate was tied for seventh lowest in the country for the same time period. Based on preliminary 2016 data, early estimates show a statewide annual average unemployment rate of 3.2 percent. Barring revision, this level would represent a five-tenths of one percentage point decrease from 2015. In addition, this would rank as Vermont’s lowest annual average unemployment rate since the year 2000.“Preliminary data for calendar year 2016 indicates more Vermonters were employed in 2016 than in 2015. If the preliminary data holds, this would be the first over-the-year rise in employed persons in four years. Going forward, increases to the number of employed persons in Vermont will become more challenging due to projected low population growth and anticipated retirements from the Baby-Boomer generation. The Vermont Department of Labor is committed to maximizing employment outcomes for all Vermonters and ensuring a skilled and adequate workforce for Vermont employers”, said Labor Commissioner Lindsay Kurrle.The seasonally-adjusted Vermont data for December show the Vermont civilian labor force increased by 200 from the prior month’s revised estimate. The number of employed increased by 500 and the number of unemployed decreased by 300. The change to the number of unemployed and the change to the unemployment rate were statistically significant in the seasonally-adjusted series.The December unemployment rates for Vermont’s 17 labor market areas ranged from 2.1 percent in White River Junction and Burlington-South Burlington to 5.0 percent in Derby (note: local labor market area unemployment rates are not seasonally-adjusted). For comparison, the December unadjusted unemployment rate for Vermont was 2.8 percent which reflects a decrease of one-tenth of one percentage point from the revised unadjusted November level and a decrease of three-tenths of one percentage point from a year ago.Not-Seasonally-Adjusted The preliminary ‘not-seasonally-adjusted’ jobs estimates for December show an increase of 4,000 jobs when compared to the revised November numbers. There was an increase of 100 jobs between the preliminary and the revised November estimates due to the inclusion of more data. The monthly increase seen in the December numbers was attributable to winter tourism activities. The broader economic trends can be detected by focusing on the over-the-year changes in this data series. As detailed in the preliminary ‘not-seasonally-adjusted’ December data, Total Private industries have increased by 600 jobs (0.2 percent) and Government (including public education) employment has increased by 700 jobs (1.2 percent) in the past year.Seasonally-Adjusted The seasonally-adjusted data for December reports an increase of 600 jobs from the revised November data. As with the ‘not-seasonally-adjusted’ data, this over-the-month change is from the revised November numbers which experienced an increase of 200 jobs from the preliminary estimates. The seasonally-adjusted over-the-month changes in December were mixed at the industry level. Those with a notable percent increase include: Construction (+800 jobs or +5.3%), Arts, Entertainment & Recreation (+200 jobs or +4.3%), and Professional & Technical Services (+300 jobs or +2.1%). Sectors with a notable percent decrease include: Transportation, Warehousing & Utilities (-300 jobs or -3.7%), Real Estate, Rental & Leasing (-100 jobs or -3.4%), and Private Educational Services (-400 jobs or -2.9%).NOTE: The Unemployment and Jobs Report for January is scheduled to be released on Monday, March 13, 2017 at 10:00 a.m. The delay is to rectify the annual report.Employment (nonfarm payroll) – A count of all persons who worked full- or part-time or received pay from a nonagricultural employer for any part of the pay period which included the 12th of the month. Because this count comes from a survey of employers, persons who work for two different companies would be counted twice. Therefore, nonfarm payroll employment is really a count of the number of jobs, rather than the number of persons employed. Persons may receive pay from a job if they are temporarily absent due to illness, bad weather, vacation, or labor-management dispute. This count is based on where the jobs are located, regardless of where the workers reside, and is therefore sometimes referred to as employment “by place of work.” Nonfarm payroll employment data are collected and compiled based on the Current Employment Statistics (CES) survey, conducted by the Vermont Department of Labor. This count was formerly referred to as nonagricultural wage and salary employment.
The Roeland Park City Council will attempt to run to ground its issues with short-term rentals in the city, spurred by the listing of several properties on Airbnb. The topic will be the focus of a special called council meeting at 6 p.m. Jan. 4.The council has been unable to agree on an approach to either allow the temporary rentals or to enforce existing ordinances that are interpreted as making them illegal in the city. The city’s attorney, Neil Shortlidge, told the council last week that Airbnb type rentals would fall under the city’s prohibitions on boarding houses. City Administrator Keith Moody also said boarding houses or tourists homes are not legal under the city’s current code.While some council members would like to allow the rentals to operate in the city, the proposals to regulate them have stalled in several long council discussions.Some councilors advocated for enforcement of the current ordinances while any long-term solution is being worked out, but the council has agreed to suggest staff suspend enforcement until mid-January. Councilor Sheri McNeil said last week she wanted to see the rentals stopped because they are against city ordinances. Councilors Ryan Kellerman and Michael Rhoades also have advocated for enforcement. “I just don’t think we pick and choose which laws we want to enforce,” Rhoades said at last week’s meeting.“Can we be any more heartless,” Councilor Becky Fast asked. She said the city should wait until after the holidays to start enforcing, the move that was eventually approved on a suggestion from Mayor Joel Marquardt.If the council comes to an agreement Monday, it could pass a change to the ordinances then. It also has a council meeting scheduled for Jan. 19.